RICERCA ITALIANA     

FIRB simili:

• 1 - BILANCIO OSPITE-TUMORE NELLA TERAPIA MEDICA DELLE NEOPLASIE: RUOLO DI NF-kB
• 2 - Nuovi approcci integrati per l'identificazione di geni bersaglio in genomi eucarioti
• 3 - Meccanismi molecolari della morte cellulare e loro implicazione in patologia umana
• 4 - Identificazione ed analisi funzionale delle alterazioni molecolari e geniche che caratterizzano i tumori della mammella ormono-responsivi
• 5 - Sviluppo di strategie per l'analisi funzionale del genoma
• 6 - Genomica e Proteomica nello studio di funzioni cellulari complesse(GAP).
• 7 - Meccanismi di regolazione dello sviluppo del sistema nervoso e del differenziamento neurale (PRONEURO)
• 8 - Epigenetica e cromatina
• 9 - Modelli transgenici per malattie ad eziologia complessa
• 10 - Modulazione razionale dell'attività antitumorale di farmaci "classici" tramite intervento selettivo su specifiche cascate regolatorie

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze biologiche
  • BIOLOGIA MOLECOLARE
• Area scientifico disciplinare: Scienze mediche
  • ONCOLOGIA MEDICA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Lombardia

Bibliografia

1. Kadonaga J.T. (1998). Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines. Cell 92, 307-13.
2. Wolffe A.P., Wong J., Li Q., Levi B.Z. & Shi Y.B. (1997). Three steps in the regulation of transcription by the thyroid hormone receptor: establishment of a repressive chromatin structure, disruption of chromatin and transcriptional activation. Biochem Soc Trans 25, 612-5.
3. Grunstein M. (1997). Histone acetylation in chromatin structure and transcription. Nature 389, 349-52.
4. Ng, H.H. & Bird A. (1999). DNA methylation and chromatin modification. Curr Opin Genet Dev 9, 158-163.
5. Kouzarides T. (1999). Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev 9, 40-8.
6. Nomura T. et al. (1999). Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 13, 412-23.
7. Giles R.H., Peters D.J. & Breuning M.H. (1998). Conjunction dysfunction: CBP/p300 in human disease. Trends Genet 14, 178-83.
8. Lin R.J., Egan D.A. & Evans R.M. (1999). Molecular genetics of acute promyelocytic leukemia. Trends Genet 15, 179-184.
9. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P.P., Donti E., Biondi A., Lo Coco F., Grignani F. & Pelicci, P. G. (1994). Acute promyelocytic leukemia: from genetics to treatment. Blood 83, 10-25.
10. Minucci S. & Pelicci P.G. (1999). Retinoid receptors in health and disease: coregulators and the chromatin connection. Seminars Cell Devel. Biol., in press.
11. Minucci S., Nervi C., Coco F.L., Pelicci P.G. (2001) Histone deacetylases: a common molecular target for differentiation treatment of acute myeloid leukemias? Oncogene, 20, 3110-3115.
12. Grignani, F., De, Matteis S., Nervi, C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F.F., Zamir I., Seiser C., Grignani F., Lazar M.A., Minucci S. & Pelicci, P.G. (1998). Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature 391, 815-8.
13. Guidez F. et al (1998). Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARa underlie molecular pathogenesis and treatment of acute promyelocytic leukemia. Blood 91, 2634-42.
14. Lin R.J., Nagy L., Inoue S., Shao W., Miller W.H., Jr. & Evans R.M. (1998). Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391, 811-4.
15. Gelmetti V., Zhang J., Fanelli M., Minucci S., Pelicci P.G. and Lazar M.A. (1998). Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol Cell Biol 18, 7185-91.
16. Hiebert S.W., Downing J.R., Lenny N. & Meyers, S. (1996). Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO. Curr Top Microbiol Immunol 211, 253-8.
17. Jones P.A. & Laird P.W.(1999). Cancer epigenetics comes of age. Nat Genet 21, 163-7.
18. Ferrara FF, Fazi F, Bianchini A, Padula F, Gelmetti V, Minucci S, Mancini M, Pelicci PG, Lo Coco F, Nervi C. (2001).Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res., 61:2-7.
19. Cameron E.E., Bachman K.E., Myohanen S., Herman J.G. & Baylin, S.B. (1999). Synergy of demethylation and histone deacetylase inhibition in the re- expression of genes silenced in cancer. Nat Genet 21, 103-7.
20. Marks P.A., Rifkind R.A., Richon V.M. and Breslow R. (2001). Inhibitors of histone deacetylase are potentially effective anticancer agents. Clin Cancer Res 7, 759-60.
21. Guarente L. Sir2links chromatin silencing, metablism, and aging. (2000) Genes & Development 14: 1021-1026.
22. Dutnall R.N. and Pillus L. (2001). Deciphering NAD-Dependent Dacetylases. Cell: 105, 161-164.
23. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999 Oct 1;13(19):2570-80.
24. Tissenbaum H.A. and Guarente L. (2000) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410, 227-230.
25. Park PU, Defossez PA, Guarente L. Effects of mutations in DNA repair genes on formation of ribosomal DNA circles and life span in Saccharomyces cerevisiae. Mol Cell Biol. 1999 May;19(5):3848-56.
26. Sinclair DA, Mills K, Guarente L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science. 1997 Aug 29;277(5330):1313-6.
27. Johnson FB, Sinclair DA, Guarente L. Molecular biology of aging. Cell. 1999 Jan 22;96(2):291-302.
28. Heo SJ, Tatebayashi K, Ohsugi I, Shimamoto A, Furuichi Y, Ikeda H. Bloom's syndrome gene suppresses premature ageing caused by Sgs1 deficiency in yeast. Genes Cells. 1999 Nov;4(11):619-25.
29. Sinclair DA, Guarente L. Extrachromosomal rDNA circles--a cause of aging in yeast. Cell. 1997 Dec 26;91(7):1033-42.
30. Wright RM, Cummings DJ. Integration of mitochondrial gene sequences within the nuclear genome during senescence in a fungus. Nature. 1983 Mar 3;302(5903):86-8.
31. Osiewacz HD, Borghouts C. Cellular copper homeostasis, mitochondrial DNA instabilities, and lifespan control in the filamentous fungus Podospora anserina. Exp Gerontol 2000 Sep;35(6-7):677-86.
32. Boultwood J, Fidler C, Mills KI, Frodsham PM, Kusec R, Gaiger A, Gale RE, Linch DC, Littlewood TJ, Moss PA, Wainscoat JS. Amplification of mitochondrial DNA in acute myeloid leukaemia. Br J Haematol. 1996 Nov;95(2):426-31.
33. Hirano T, Shiraishi K, Adachi K, Miura S, Watanabe H, Utiyama H. Co-localization of mitochondrial and double minute DNA in the nuclei of HL-60 cells but not normal cells. Mutat Res. 1999 Apr 6;425(2):195-204.
34. Katsumata K, Hayakawa M, TanakaM, Sugiyama S, Ozawa T. Fragmentation of human heart mitochondrial DNA associated with premature aging. Biochem Biophys Res Commun. 1994 Jul 15;202(1):102-10.
35. Hayakawa M, Katsumata K, Yoneda M, Tanaka M, Sugiyama S, Ozawa T. Mitochondrial DNA minicircles, lacking replication origins, exist in the cardiac muscle of a young normal subject. Biochem Biophys Res Commun. 1995 Oct 24;215(3):952-60.
36. Gray S.G. & Ekstrom T.J. (2001). The human histone deacetylase family. Exp. Cell Research 262, 75-83.
37. Taunton J., Hassing C.A. & Schreiber S.L. (1996). A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. Science 272, 408-411.
38. Yang W.M., Inouye C., Zeng Y., Bearss D. & Seto E. (1996). Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc. Natl. Acad Sci. USA 93,12845-12850.
39. Hu E., Chen Z., Fredrickson Y., Kirkpatrick R., Zhang G.F., Johanson K., Sung C.M., Liu R. and Winkler J. (2000). Cloning and characterization of a novel human class I histone diacetylase that functions as a transcription repressor. J. Biol. Chem. 275,15254-15264.
40. Rundlett S.E., Carmen A.A., Kobayashi R., Bavykin S., Turner B.M. & Grunstein M. (1996). HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad Sci. USA 93, 14503-14508.
41.Wang A.H. et al . (1999). HDAC4, a human histone deacetylase related to yeast HDA1, is a transcriptional corepressor. Mol. Cell. Biol. 19,7816-7827.
42.Guarente L. (2000). Sir2 links chromatin silencing, metabolism and aging. Genes Dev. 14,1021-1026.
43. Afshar G. & Murnane J.P. (1999). Characterization of a humane gene with sequence homology to Saccharomyces cerevisiae SIR2. Gene 234,161-168.
44. Frye R. A. (1999). Characterization of five human cDNAswith homologyto the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. BBRC 260, 273-279.
45. Migliaccio E., Giorgio M., Mele S., Pelicci G., Pandolfi P.P., Lanfrancone L. & Pelicci P.G. The p66shc adaptor protein controls oxidative stress response and lifespan in mammals. Nature, 402(6759):309-13, 1999.

Parole Chiave

Istone deacetilasi; cromatina; cancro; invecchiamento; nuovi farmaci; trattamenti differenziativi